Catheter Precision (VTAK) Net Cash Flow Growth (5y) (2022 - 2026)
Catheter Precision (VTAK) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Catheter Precision | 603,191.91 | 203,191.91 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.38% |
| Dec 31, 2025 | 36.69% |
| Sep 30, 2025 | -43.95% |
| Jun 30, 2025 | -48.69% |
| Mar 31, 2025 | -21.33% |
| Dec 31, 2024 | 86.05% |
| Sep 30, 2024 | -14.41% |
| Jun 30, 2024 | 49.14% |
| Mar 31, 2024 | 25.74% |
| Dec 31, 2023 | -15.26% |
| Sep 30, 2023 | 17.72% |
| Jun 30, 2023 | -30.54% |
| Mar 31, 2023 | -25.84% |
| Dec 31, 2022 | -21.24% |